Company Profile
Biohaven Stock Price, News & Analysis
- Ticker:
- BHVN
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Biohaven is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
14.78 USD (-4.65%)
Close
Last updated: June 23, 2026 at 00:00
2.23B USD
Market cap
Why the stock is moving
BHVN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Biohaven is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Biohaven is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Biohaven follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Biohaven sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Biohaven (BHVN)?
Biohaven (BHVN) most recently closed at 14.78 USD, a -4.65% move versus the previous session.
What is the market cap of Biohaven (BHVN)?
Biohaven currently has a market capitalization of 2.23B USD on BioPharmSignal.
What does Biohaven do?
Biohaven is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is BHVN stock listed?
Biohaven (BHVN) is associated with NYSE, Headquartered in the United States and listed on NYSE, Biohaven is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Biohaven?
Biohaven is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Biohaven targeting with Biohaven?
Biohaven is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.